Doxepin 100 MG Oral Capsule — RxCUI 1000058
RxNorm drug concept · Semantic clinical drug
RxCUI 1000058
Semantic clinical drug · SCD
● Current RxNorm concept 114 FDA products
190 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1000058
Official nameDoxepin 100 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdoxepin (as doxepin HCl) 100 MG Oral Capsule; doxepin HCl 100 MG Oral Capsule
FDA products mapped114
Package NDCs mapped190
Reported Medicaid activity (SDUD)520,368 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Doxepin Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It calms moderate itching in adults who have atopic dermatitis or lichen simplex chronicus. It is meant for short-term use, up to 8 days.
- Put on a thin film four times a day, with at least 3 to 4 hours between applications. Don't wrap or cover the area with airtight dressings. Stop after 8 days unless your prescriber...
- It might. About 1 in 5 people felt drowsy, and it is more likely if you treat a large area. Avoid driving or machinery until you know how it affects you, and skip alcohol or other...
- Burning or stinging where you apply it is the most common, along with drowsiness and dry mouth. Call your doctor if the burning is severe or the sleepiness is too much. They may ad...
🕸️ Concept Web — How Doxepin 100 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Doxepin 100 MG Oral Capsule
RxCUI 1000058 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Doxepin
3638IN
-
Doxepin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Doxepin Oral Capsule
371962SCDF -
Doxepin Oral Product
1160768SCDG -
Doxepin Pill
1160769SCDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Doxepin Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Doxepin 100 MG
330430SCDC
-
Doxepin 100 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Doxepin 100 MG
SCDC · 330430 -
Doxepin Oral Capsule
SCDF · 371962 -
Doxepin Oral Product
SCDG · 1160768 -
Doxepin Pill
SCDG · 1160769
📦 FDA Products & Package NDCs
114 products · 190 package NDCs
190 package NDCs map to RxCUI 1000058 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-1049-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1049-01) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-1049-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-1049-10) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-3125-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3125-01) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-3125-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-3125-10) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-4250-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-4250-01) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-4250-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-4250-10) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-5375-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-5375-01) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-5375-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-5375-10) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-6410-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-6410-01) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00378-6410-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-6410-10) | Doxepin Hydrochloride | Mylan Pharmaceuticals Inc. | 1986-05-13 |
| 00904-7052-61 | 100 BLISTER PACK in 1 CARTON (0904-7052-61) / 1 CAPSULE in... | Doxepin Hydrochloride | Major Pharmaceuticals | 2017-06-28 |
| 00904-7053-61 | 100 BLISTER PACK in 1 CARTON (0904-7053-61) / 1 CAPSULE in... | Doxepin Hydrochloride | Major Pharmaceuticals | 2017-06-28 |
| 00904-7054-61 | 100 BLISTER PACK in 1 CARTON (0904-7054-61) / 1 CAPSULE in... | Doxepin Hydrochloride | Major Pharmaceuticals | 2017-06-28 |
| 00904-7055-61 | 100 BLISTER PACK in 1 CARTON (0904-7055-61) / 1 CAPSULE in... | Doxepin Hydrochloride | Major Pharmaceuticals | 2017-06-28 |
| 10267-5059-04 | 1000 CAPSULE in 1 BOTTLE (10267-5059-4) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5059-09 | 90 CAPSULE in 1 BOTTLE (10267-5059-9) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5060-04 | 1000 CAPSULE in 1 BOTTLE (10267-5060-4) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5060-09 | 90 CAPSULE in 1 BOTTLE (10267-5060-9) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5061-04 | 1000 CAPSULE in 1 BOTTLE (10267-5061-4) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5061-09 | 90 CAPSULE in 1 BOTTLE (10267-5061-9) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5062-04 | 1000 CAPSULE in 1 BOTTLE (10267-5062-4) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5062-09 | 90 CAPSULE in 1 BOTTLE (10267-5062-9) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5063-04 | 1000 CAPSULE in 1 BOTTLE (10267-5063-4) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 10267-5063-09 | 90 CAPSULE in 1 BOTTLE (10267-5063-9) | Doxepin Hydrochloride | Contract Pharmacal Corp. | 2021-01-24 |
| 23155-0794-01 | 100 CAPSULE in 1 BOTTLE (23155-794-01) | DOXEPIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-12-30 |
| 23155-0795-01 | 100 CAPSULE in 1 BOTTLE (23155-795-01) | DOXEPIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-12-30 |
| 23155-0796-01 | 100 CAPSULE in 1 BOTTLE (23155-796-01) | DOXEPIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-12-30 |
| 23155-0797-01 | 100 CAPSULE in 1 BOTTLE (23155-797-01) | DOXEPIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-12-30 |
| 23155-0798-01 | 100 CAPSULE in 1 BOTTLE (23155-798-01) | DOXEPIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-12-30 |
| 24658-0793-01 | 100 CAPSULE in 1 BOTTLE (24658-793-01) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0793-10 | 1000 CAPSULE in 1 BOTTLE (24658-793-10) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0794-01 | 100 CAPSULE in 1 BOTTLE (24658-794-01) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0794-10 | 1000 CAPSULE in 1 BOTTLE (24658-794-10) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0795-01 | 100 CAPSULE in 1 BOTTLE (24658-795-01) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0795-10 | 1000 CAPSULE in 1 BOTTLE (24658-795-10) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0796-01 | 100 CAPSULE in 1 BOTTLE (24658-796-01) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0796-10 | 1000 CAPSULE in 1 BOTTLE (24658-796-10) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0797-01 | 100 CAPSULE in 1 BOTTLE (24658-797-01) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0797-05 | 500 CAPSULE in 1 BOTTLE (24658-797-05) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 24658-0797-10 | 1000 CAPSULE in 1 BOTTLE (24658-797-10) | Doxepin Hydrochloride | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2023-03-14 |
| 27241-0167-01 | 100 CAPSULE in 1 BOTTLE (27241-167-01) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2019-12-20 |
| 27241-0167-10 | 1000 CAPSULE in 1 BOTTLE (27241-167-10) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2020-02-20 |
| 27241-0168-01 | 100 CAPSULE in 1 BOTTLE (27241-168-01) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2019-12-20 |
| 27241-0168-10 | 1000 CAPSULE in 1 BOTTLE (27241-168-10) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2020-02-20 |
| 27241-0169-01 | 100 CAPSULE in 1 BOTTLE (27241-169-01) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2019-12-20 |
| 27241-0169-10 | 1000 CAPSULE in 1 BOTTLE (27241-169-10) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2020-02-20 |
| 27241-0170-01 | 100 CAPSULE in 1 BOTTLE (27241-170-01) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2019-12-20 |
| 27241-0170-10 | 1000 CAPSULE in 1 BOTTLE (27241-170-10) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2020-02-20 |
| 27241-0171-01 | 100 CAPSULE in 1 BOTTLE (27241-171-01) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2019-12-20 |
| 27241-0171-10 | 1000 CAPSULE in 1 BOTTLE (27241-171-10) | Doxepin hydrochloride | Ajanta Pharma USA Inc. | 2020-02-20 |
Observed labelers:
Amneal Pharmaceuticals NY LLC (15) ·
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS (11) ·
Ajanta Pharma USA Inc. (10) ·
Alembic Pharmaceuticals Inc. (10) ·
Alembic Pharmaceuticals Limited (10) ·
Appco Pharma LLC (10)
· +19 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.